Celogen Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 03-07-2024
- Paid Up Capital ₹ 1.00 M
as on 03-07-2024
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2022
- Revenue -97.72%
(FY 2021)
- Profit -43.06%
(FY 2021)
- Ebitda
- Net Worth -0.14%
(FY 2021)
- Total Assets -0.19%
(FY 2021)
About Celogen Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Thykoottathil Matthews, Rabi Nayak, and Vijaykumar Nair serve as directors at the Company.
- CIN/LLPIN
U51109MH2012PTC226572
- Company No.
226572
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Feb 2012
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Navi Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Celogen Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rabi Nayak  | Director | 02-Feb-2012 | Current |
| Vijaykumar Nair | Director | 02-Feb-2012 | Current |
| Thykoottathil Matthews | Director | 02-Feb-2012 | Current |
Financial Performance and Corporate Structure Insights of Celogen Laboratories.
Celogen Laboratories Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 97.72% decrease. The company also saw a substantial fall in profitability, with a 43.06% decrease in profit. The company's net worth dipped by a decrease of 0.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Celogen Laboratories?
In 2021, Celogen Laboratories had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Celogen Pharma Private LimitedActive 19 years 8 monthsThykoottathil Matthews and Vijaykumar Nair are mutual person
Gpax Pharmaceuticals Private LimitedActive 10 years 2 monthsThykoottathil Matthews, Rabi Nayak and 1 more are mutual person
Agam And Gem Laboratories Private LimitedActive 28 years 11 monthsThykoottathil Matthews, Rabi Nayak and 1 more are mutual person
- Celogen Lifescience & Technologies Private LimitedActive 14 years 1 month
Thykoottathil Matthews, Rabi Nayak and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Celogen Laboratories?
Unlock and access historical data on people associated with Celogen Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Celogen Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Celogen Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
